Back to top

Annexon initiated with an Underperform at Citizens

Citizens initiated coverage of Annexon (ANNX) with an Underperform rating and $3 price target The company is developing first-in-class C1q inhibito...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Annexon, Inc. (ANNX)